Gamifant
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ontario, CanadaPhone Number
(833) 597-6530Website
www.gamifant.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Gamifant
Sobi is a biopharmaceutical company dedicated to providing innovative treatments for ultra-rare diseases. They offer Gamifant, an FDA-approved interferon gamma-blocking antibody for treating primary hemophagocytic lymphohistiocytosis (HLH) in both adults and children. Their focus is on addressing the challenges faced by patients and caregivers throughout the healthcare journey. Sobi collaborates with healthcare professionals and advocacy groups to ensure comprehensive support and access to necessary therapies.Explore more
Popular SearchesGamifantSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gamifant your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Gamifant is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Gamifant
Check if Gamifant has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Gamifant recently announced quarterly report
Product Launch: Get notified when Gamifant launches new products
Click to see if Gamifant had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Gamifant has new funding data
Gamifant, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Gamifant
Compare insights from companies similar to Gamifant, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Gamifant
$5.1M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Gamifant is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gamifant is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gamifant.
Gamifant Tech Stack
A closer look at the technologies used by Gamifant
See more technologies
Gamifant News & Media
Sobi and Novimmune Selected as Honourees for 2019 National Organization for Rare Disorders (NORD) Rare Impact Award in Industry Innovation for Gamifant® (emapalumab)
STOCKHOLM, March 25, 2019 /PRNewswire/ -- Sobi™ and Novimmune SA have both been selected as honourees by the National Organization for Rare Disorders (NORD) for the 2019 Rare Impact Awards. The companies were nominated in the category of Industry Innovation in recognition of the US Food...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Gamifant
Sign Up For FreeTo access detailed company insights
Sobi is a biopharmaceutical company dedicated to providing innovative treatments for ultra-rare diseases. They offer Gamifant, an FDA-approved interferon gamma-blocking antibody for treating primary hemophagocytic lymphohistiocytosis (HLH) in both adults and children. Their focus is on addressing the challenges faced by patients and caregivers thro... Read More
